-
公开(公告)号：US12018072B2
公开(公告)日：2024-06-25
申请号：US18456323
申请日：2023-08-25
Applicant: MORPHOSYS AG
Inventor： Julia Neugebauer , Barbara Bachler-Konetzki , Tanja Herrmann , Winfried Elis
CPC classification number: C07K16/18 , A61K2039/505 , C07K2317/14 , C07K2317/21 , C07K2317/33 , C07K2317/35 , C07K2317/72 , C07K2317/732 , C07K2317/76 , C07K2317/92
Abstract: The present invention provides novel antibodies or antibody fragments specifically binding to human C5aR. In particular, it relates to antibodies or antibody fragments that have combined beneficial properties and are therefore useful for the treatment of inflammatory or autoimmune diseases or cancer.
-
公开(公告)号：US20240018225A1
公开(公告)日：2024-01-18
申请号：US18456323
申请日：2023-08-25
Applicant: MORPHOSYS AG
Inventor： Julia Neugebauer , Barbara Bachler-Konetzki , Tanja Herrmann , Winfried Elis
IPC: C07K16/28
CPC classification number: C07K16/2896 , A61K2039/505
Abstract: The present invention provides novel antibodies or antibody fragments specifically binding to human C5aR. In particular, it relates to antibodies or antibody fragments that have combined beneficial properties and are therefore useful for the treatment of inflammatory or autoimmune diseases or cancer.
-
公开(公告)号：US20240400657A1
公开(公告)日：2024-12-05
申请号：US18658860
申请日：2024-05-08
Applicant: MORPHOSYS AG
Inventor： Julia Neugebauer , Barbara Bachler-Konetzki , Tanja Herrmann , Winfried Elis
Abstract: The present invention provides novel antibodies or antibody fragments specifically binding to human C5aR. In particular, it relates to antibodies or antibody fragments that have combined beneficial properties and are therefore useful for the treatment of inflammatory or autoimmune diseases or cancer.
-
-
Search Results
3
records
(took 0.012 seconds)
